| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9B | $5.3B | $3.9B | $3.6B | $1.6B | $0.1B | $0.5B | $0.6B |
| Cost of Revenue | $1.0B | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.2B | $1.1B | $1.3B | $1.6B | $0.8B | $0.0B | $0.0B | $0.1B |
| Net Income | $0.0B | $0.8B | $1.0B | $1.9B | $0.3B | $-0.0B | $-0.1B | $0.2B |
| EPS (Basic) | $0.74 | $16.32 | $24.59 | $60.86 | $16.15 | $-2.50 | $-0.24 | $0.71 |
| EPS (Diluted) | $0.74 | $16.02 | $23.51 | $57.55 | $15.48 | $-2.50 | $-0.24 | $0.70 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.1B | $13.0B | $6.9B | $6.6B | $3.0B | $2.2B | $7.5B | $7.6B |
| Current Assets | $1.5B | $1.6B | $1.4B | $1.5B | $1.6B | $0.3B | $0.4B | $0.6B |
| Cash & Equivalents | $0.2B | $0.0B | $0.3B | $0.6B | $0.2B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $5.0B | $4.3B | $1.8B | $2.0B | $1.8B | $1.1B | $3.7B | $3.7B |
| Current Liabilities | $1.5B | $1.7B | $1.2B | $1.4B | $1.2B | $0.3B | $0.6B | $0.6B |
| Stockholders' Equity | $8.1B | $8.7B | $5.1B | $4.7B | $1.0B | $0.9B | $3.6B | $3.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.0B | $2.1B | $1.8B | $1.9B | $0.9B | $0.1B | $0.9B | $1.0B |
| Investing Cash Flow | $-1.8B | $-1.8B | $-1.4B | $-0.7B | $-0.9B | $-0.0B | $-0.8B | $-1.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.1B | $-0.6B | $-0.7B | $-0.8B | $0.2B | $-0.1B | $-0.1B | $0.6B |